Renaissance Technologies’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.22M Sell
1,508,210
-767,900
-34% -$2.66M 0.01% 1499
2025
Q1
$5.96M Buy
2,276,110
+726,920
+47% +$1.9M 0.01% 1323
2024
Q4
$6.38M Buy
1,549,190
+878,095
+131% +$3.62M 0.01% 1287
2024
Q3
$4.75M Sell
671,095
-237,942
-26% -$1.68M 0.01% 1469
2024
Q2
$5.93M Buy
909,037
+145,837
+19% +$951K 0.01% 1200
2024
Q1
$6.34M Buy
763,200
+439,500
+136% +$3.65M 0.01% 1262
2023
Q4
$3.56M Buy
323,700
+179,000
+124% +$1.97M 0.01% 1563
2023
Q3
$1.22M Buy
+144,700
New +$1.22M ﹤0.01% 2167
2023
Q2
Sell
-118,854
Closed -$1.96M 4216
2023
Q1
$1.96M Buy
118,854
+58,054
+95% +$956K ﹤0.01% 2041
2022
Q4
$908K Buy
+60,800
New +$908K ﹤0.01% 2590
2022
Q3
Sell
-25,900
Closed -$434K 4347
2022
Q2
$434K Sell
25,900
-1,900
-7% -$31.8K ﹤0.01% 3237
2022
Q1
$832K Buy
27,800
+20,800
+297% +$623K ﹤0.01% 2852
2021
Q4
$215K Sell
7,000
-145,588
-95% -$4.47M ﹤0.01% 3482
2021
Q3
$4.81M Buy
+152,588
New +$4.81M 0.01% 1488